Decrease of Deleted in Malignant Brain Tumour‐1 (DMBT‐1) expression is a crucial late event in intrahepatic cholangiocarcinoma
M Sasaki(Kanazawa University), Yasuni Nakanuma(Fukui-ken Saiseikai Hospital), Akira Ishikawa(Kanazawa University), Koji Oda(Tokyo Metropolitan University), Jan Mollenhauer, M. Chen(Chang Gung University), S‐F Huang, T‐S Yeh(Chang Gung University), Annemarie Poustka(German Cancer Research Center), YY Jan(Chang Gung University), Y Nimura(Aichi Cancer Center), Koichi Tsuneyama(Tokushima University)
Cited by 17
Related Papers
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396
cHCC‐CCA
|Hepatology|2018|333
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English edition
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|300